These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11336616)

  • 1. Citalopram: a comprehensive review.
    Pollock BG
    Expert Opin Pharmacother; 2001 Apr; 2(4):681-98. PubMed ID: 11336616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram--a review of pharmacological and clinical effects.
    Bezchlibnyk-Butler K; Aleksic I; Kennedy SH
    J Psychiatry Neurosci; 2000 May; 25(3):241-54. PubMed ID: 10863884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escitalopram: better treatment for depression is through the looking glass.
    Malin P; Wengel SP; Burke WJ
    Expert Rev Neurother; 2004 Sep; 4(5):769-79. PubMed ID: 15853504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing depressive and anxiety disorders with escitalopram.
    Thase ME
    Expert Opin Pharmacother; 2006 Mar; 7(4):429-40. PubMed ID: 16503815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.
    Bareggi SR; Mundo E; Dell'Osso B; Altamura AC
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):741-53. PubMed ID: 17916059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram in the treatment of depression and other potential uses in psychiatry.
    Tan JY; Levin GM
    Pharmacotherapy; 1999 Jun; 19(6):675-89. PubMed ID: 10391413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology review of escitalopram for the treatment of depression.
    Pastoor D; Gobburu J
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):121-8. PubMed ID: 24289655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
    Bourin M
    Hum Psychopharmacol; 2003 Apr; 18(3):185-90. PubMed ID: 12672169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Citalopram].
    El-Armouche A; Zolk O; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
    [No Abstract]   [Full Text] [Related]  

  • 16. Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials.
    Keller MB
    J Clin Psychiatry; 2000 Dec; 61(12):896-908. PubMed ID: 11206593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of citalopram in patients with obsessive-compulsive disorder].
    Jakitowicz J; Nowicki Z; Wiśniewski G
    Psychiatr Pol; 2002; 36(6 Suppl):297-301. PubMed ID: 12647452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram for depression.
    Med Lett Drugs Ther; 1998 Dec; 40(1041):113-4. PubMed ID: 9854566
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications.
    Parry BL
    CNS Drugs; 2001; 15(4):277-85. PubMed ID: 11463133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.